Literature DB >> 3348748

The interaction between native serum albumin and hepatitis B virus.

X Y Lu1, G B Yao, Y F Tian.   

Abstract

Purified hepatitis B virus particles were obtained from HBeAg positive serum by sucrose gradient ultracentrifugation and sephadex G-200 gel filtration. These virions formed a precipitation line in counterimmune electrophoresis with anti-albumin antibody, but the reaction could be inhibited by anti-HBs. After two months at 4 degrees C, another precipitating line was formed under the same condition which could not be inhibited by anti-HBs and was, thus, due to free albumin. When that sample was incubated at 37 degrees C overnight, the line of free albumin disappeared. The virion bound albumin was monomeric in non-denaturing gel electrophoresis. These results suggest that a reversible binding between virion and albumin may occur in vivo and does not require chemical modification or cross-linking.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3348748     DOI: 10.1007/bf01322166

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  17 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Large surface proteins of hepatitis B virus containing the pre-s sequence.

Authors:  K H Heermann; U Goldmann; W Schwartz; T Seyffarth; H Baumgarten; W H Gerlich
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

3.  Polyalbumin receptors: their role in the attachment of hepatitis B virus to hepatocytes.

Authors:  S N Thung; M A Gerber
Journal:  Semin Liver Dis       Date:  1984-02       Impact factor: 6.115

4.  Analysis of hepatitis B surface antigen components solubilized with Triton X-100.

Authors:  J Skelly; C R Howard; A J Zuckerman
Journal:  J Gen Virol       Date:  1979-09       Impact factor: 3.891

5.  A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg.

Authors:  M Imai; Y Yanase; T Nojiri; Y Miyakawa; M Mayumi
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

6.  Characterisation of the polymerised and monomeric human serum albumin binding sites on hepatitis B surface antigen.

Authors:  K Ishihara; J A Waters; M Pignatelli; H C Thomas
Journal:  J Med Virol       Date:  1987-01       Impact factor: 2.327

7.  A polypeptide containing 55 amino acid residues coded by the pre-S region of hepatitis B virus deoxyribonucleic acid bears the receptor for polymerized human as well as chimpanzee albumins.

Authors:  A Machida; S Kishimoto; H Ohnuma; K Baba; Y Ito; H Miyamoto; G Funatsu; K Oda; S Usuda; S Togami
Journal:  Gastroenterology       Date:  1984-05       Impact factor: 22.682

8.  Antigenic relationship of a hepatitis B surface antigen-derived polypeptide and human serum albumin.

Authors:  Y Sanchez; I Ionescu-Matiu; F B Hollinger; J L Melnick; G R Dreesman
Journal:  J Gen Virol       Date:  1980-06       Impact factor: 3.891

9.  Production of potent anti-Australia antigen sera of high specificity and sensitivity in goats.

Authors:  G R Dreesman; F B Hollinger; R M McCombs; J L Melnick
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

10.  Interaction between various polymerized human albumins and hepatitis B surface antigen.

Authors:  M W Yu; J S Finlayson; J W Shih
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

View more
  3 in total

Review 1.  The pathogenetic basis of viral tropism.

Authors:  C A Mims
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

2.  Study of the early steps of the Hepatitis B Virus life cycle.

Authors:  Xuanyong Lu; Timothy Block
Journal:  Int J Med Sci       Date:  2004-03-10       Impact factor: 3.738

3.  Albumin Binds COVID-19 Spike 1 Subunit and Predicts In-Hospital Survival of Infected Patients-Possible Alteration by Glucose.

Authors:  Khaoula Zekri-Nechar; José J Zamorano-León; Antonio Segura-Fragoso; José R Alcaide; Carmen Reche; Alcira Andrés-Castillo; Carlos H Martínez-Martínez; Manel Giner; Rodrigo Jiménez-García; Ana López-de-Andrés; Carlos Navarro-Cuellar; Miguel A García-Fernández; Antonio López-Farré
Journal:  J Clin Med       Date:  2022-01-25       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.